Modified version of CAR T-cell therapy shows promise in targeting neuroblastoma
Now, a group of scientists at Children's Hospital Los Angeles have developed a modified version of CAR T that shows promise in targeting neuroblastoma, spares healthy brain tissue and more effectively kills cancer cells.